CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 137 filers reported holding CYTOKINETICS INC in Q1 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,209 | -5.3% | 7,373 | +4.8% | 0.00% | – |
| Q2 2023 | $229,417 | -5.0% | 7,033 | +2.4% | 0.00% | – |
| Q1 2023 | $241,614 | -22.9% | 6,866 | +0.4% | 0.00% | – |
| Q4 2022 | $313,226 | -6.2% | 6,836 | -0.6% | 0.00% | – |
| Q3 2022 | $334,000 | +30.0% | 6,880 | +5.5% | 0.00% | – |
| Q2 2022 | $257,000 | +8.9% | 6,520 | +1.0% | 0.00% | – |
| Q1 2022 | $236,000 | -14.5% | 6,454 | +6.1% | 0.00% | – |
| Q4 2021 | $276,000 | +27.2% | 6,082 | -0.2% | 0.00% | – |
| Q3 2021 | $217,000 | +121.4% | 6,097 | +22.8% | 0.00% | – |
| Q2 2021 | $98,000 | -14.8% | 4,966 | +1.0% | 0.00% | – |
| Q1 2021 | $115,000 | +29.2% | 4,917 | +16.1% | 0.00% | – |
| Q4 2020 | $89,000 | +2.3% | 4,236 | +5.7% | 0.00% | – |
| Q3 2020 | $87,000 | -6.5% | 4,006 | +0.3% | 0.00% | – |
| Q2 2020 | $93,000 | +93.8% | 3,993 | -0.0% | 0.00% | – |
| Q1 2020 | $48,000 | +17.1% | 3,994 | +3.3% | 0.00% | – |
| Q4 2019 | $41,000 | +2.5% | 3,868 | +9.5% | 0.00% | – |
| Q3 2019 | $40,000 | -52.4% | 3,531 | -52.2% | 0.00% | – |
| Q2 2019 | $84,000 | +55.6% | 7,393 | +10.3% | 0.00% | – |
| Q1 2019 | $54,000 | +12.5% | 6,701 | -10.5% | 0.00% | – |
| Q4 2018 | $48,000 | -29.4% | 7,491 | +9.4% | 0.00% | – |
| Q3 2018 | $68,000 | +21.4% | 6,848 | +2.3% | 0.00% | – |
| Q2 2018 | $56,000 | +27.3% | 6,696 | +8.4% | 0.00% | – |
| Q1 2018 | $44,000 | +7.3% | 6,177 | +21.9% | 0.00% | – |
| Q4 2017 | $41,000 | -54.4% | 5,069 | -18.3% | 0.00% | – |
| Q3 2017 | $90,000 | -91.2% | 6,206 | -92.7% | 0.00% | -100.0% |
| Q2 2017 | $1,022,000 | -5.2% | 84,509 | +0.8% | 0.00% | 0.0% |
| Q1 2017 | $1,078,000 | -47.6% | 83,821 | -50.5% | 0.00% | -50.0% |
| Q4 2016 | $2,056,000 | +28.8% | 169,216 | -2.6% | 0.00% | 0.0% |
| Q3 2016 | $1,596,000 | -24.1% | 173,794 | -21.5% | 0.00% | 0.0% |
| Q2 2016 | $2,104,000 | +4909.5% | 221,522 | +3697.7% | 0.00% | – |
| Q1 2016 | $42,000 | -31.1% | 5,833 | 0.0% | 0.00% | – |
| Q4 2015 | $61,000 | +8.9% | 5,833 | -30.0% | 0.00% | – |
| Q3 2015 | $56,000 | +115.4% | 8,333 | +117.4% | 0.00% | – |
| Q2 2015 | $26,000 | +30.0% | 3,833 | +35.3% | 0.00% | – |
| Q1 2015 | $20,000 | +185.7% | 2,833 | +240.1% | 0.00% | – |
| Q4 2014 | $7,000 | +133.3% | 833 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | -25.0% | 833 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | -50.0% | 833 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | +60.0% | 833 | 0.0% | 0.00% | – |
| Q4 2013 | $5,000 | -37.5% | 833 | -16.6% | 0.00% | – |
| Q3 2013 | $8,000 | – | 999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |